Mountain View
biomedical and healthCAre Data Discovery Index Ecosystem
help Advanced Search
Title: Phase 2, Double-Blind, Placebo-Controlled Trial Of Reserpine For The Treatment Of Cocaine Dependence      
ID:
NIDA-CTO-0001
creators:
Eugene Somoza, M.D.
privacy:
information not available
keywords:
reserpine; phase 2b; cocaine; stimulant
refinement:
curated
types:
clinical trial
dateReleased:
12-04-2014
aggregation:
instance of dataset
availability:
available
description:
The primary objective of this study is to assess the efficacy of reserpine in reducing cocaine use in subjects with cocaine dependence (DSM-IV criteria). The hypothesis is that reserpine will increase the weekly mean proportion of cocaine non-use days over the treatment period when compared to placebo as determined by self-report of cocaine use confirmed with urine assays for BE.
name:
Homo sapiens
ID:
SCR:011440
homePage: http://www.nida.nih.gov/
abbreviation:
NIDA
name:
National Institute on Drug Abuse
ID:
SCR:002002
homePage: http://datashare.nida.nih.gov/
abbreviation:
CTN
name:
Clinical Trials Network Data Share

Feedback?

If you are having problems using our tools, or if you would just like to send us some feedback, please post your questions on GitHub.